These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 21174219

  • 1. Single daily high-dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporine administration.
    Fujinaga S, Hirano D, Nishizaki N, Someya T, Ohtomo Y, Ohtsuka Y, Shimizu T, Kaneko K.
    Pediatr Nephrol; 2011 Mar; 26(3):479-83. PubMed ID: 21174219
    [Abstract] [Full Text] [Related]

  • 2. High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity.
    Ohtomo Y, Fujinaga S, Takada M, Murakami H, Akashi S, Shimizu T, Kaneko K, Yamashiro Y.
    Pediatr Nephrol; 2005 Dec; 20(12):1744-9. PubMed ID: 16133041
    [Abstract] [Full Text] [Related]

  • 3. Effect of single-dose oral mizoribine pulse therapy twice per week for frequently relapsing steroid-dependent nephrotic syndrome.
    Fujieda M, Ishihara M, Morita T, Hayashi A, Okada S, Ohta T, Sakano T, Wakiguchi H.
    Clin Nephrol; 2012 Jul; 78(1):40-6. PubMed ID: 22732336
    [Abstract] [Full Text] [Related]

  • 4. Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome.
    Mizutani A, Fujinaga S, Sakuraya K, Hirano D, Shimizu T.
    Clin Exp Nephrol; 2019 Feb; 23(2):244-250. PubMed ID: 30121800
    [Abstract] [Full Text] [Related]

  • 5. Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome.
    Aizawa-Yashiro T, Tsuruga K, Watanabe S, Oki E, Ito E, Tanaka H.
    Pediatr Nephrol; 2011 Aug; 26(8):1255-61. PubMed ID: 21479767
    [Abstract] [Full Text] [Related]

  • 6. Assessment of factors associated with mizoribine responsiveness in children with steroid-dependent nephrotic syndrome.
    Kondoh T, Ikezumi Y, Yokoi K, Nakajima Y, Matsumoto Y, Kaneko M, Hasegawa H, Yamada T, Kumagai N, Ito T, Yoshikawa T.
    Clin Exp Nephrol; 2019 Sep; 23(9):1154-1160. PubMed ID: 31187341
    [Abstract] [Full Text] [Related]

  • 7. Is single-daily low-dose cyclosporine therapy really effective in children with idiopathic frequent-relapsing nephrotic syndrome?
    Fujinaga S, Ohtomo Y, Someya T, Shimizu T, Yamashiro Y, Kaneko K.
    Clin Nephrol; 2008 Feb; 69(2):84-9. PubMed ID: 18218301
    [Abstract] [Full Text] [Related]

  • 8. C1-C2 point monitoring of low-dose cyclosporin a given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome.
    Nakahata T, Tanaka H, Tsugawa K, Kudo M, Suzuki K, Ito E, Waga S.
    Clin Nephrol; 2005 Oct; 64(4):258-63. PubMed ID: 16240896
    [Abstract] [Full Text] [Related]

  • 9. Predictors of Treatment Response and Long-Term Outcomes in Young Children with Steroid-Dependent Nephrotic Syndrome Treated with High-Dose Mizoribine as First-Line Steroid-Sparing Agent.
    Fujinaga S, Endo S, Morishita T, Takemasa Y, Onuki Y, Sakuraya K, Hirano D.
    Tohoku J Exp Med; 2022 Jan; 256(1):85-91. PubMed ID: 35095030
    [Abstract] [Full Text] [Related]

  • 10. Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome.
    Kawasaki Y, Hosoya M, Kobayashi S, Ohara S, Onishi N, Takahashi A, Isome M, Suzuki H.
    Nephrol Dial Transplant; 2005 Oct; 20(10):2243-7. PubMed ID: 16030039
    [Abstract] [Full Text] [Related]

  • 11. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 12. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases.
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
    [Abstract] [Full Text] [Related]

  • 13. [Beneficial and adverse effects of high-dosage MZR therapy in the management of children with frequently relapsing nephrotic syndrome].
    Goto M, Ikeda M, Hataya H, Ishikura K, Hamasaki Y, Honda M.
    Nihon Jinzo Gakkai Shi; 2006 Mar; 48(4):365-70. PubMed ID: 16780106
    [Abstract] [Full Text] [Related]

  • 14. Maintenance therapy with single-daily, high-dose mizoribine after cyclophosphamide therapy for prepubertal boys with severe steroid-dependent nephrotic syndrome.
    Fujinaga S, Endo A, Watanabe T, Hirano D, Ohtomo Y, Shimizu T, Kaneko K.
    Clin Nephrol; 2012 Sep; 78(3):251-2. PubMed ID: 22541687
    [No Abstract] [Full Text] [Related]

  • 15. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
    Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
    BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
    [Abstract] [Full Text] [Related]

  • 16. Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.
    Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Sasatomi Y, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y, Refractory Nephrotic Syndrome Study Group.
    Clin Exp Nephrol; 2017 Dec 01; 21(6):961-970. PubMed ID: 27783276
    [Abstract] [Full Text] [Related]

  • 17. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
    Hama T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Sako M, Saito-Oba M, Nozu K, Shima Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC).
    BMC Nephrol; 2018 Sep 10; 19(1):223. PubMed ID: 30200895
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine.
    Fujinaga S, Hirano D, Nishino T, Umeda C, Watanabe Y, Nakagawa M.
    Pediatr Nephrol; 2019 Nov 10; 34(11):2417-2421. PubMed ID: 31435725
    [Abstract] [Full Text] [Related]

  • 19. Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.
    Hino S, Takemura T, Okada M, Murakami K, Yagi K, Fukushima K, Yoshioka K.
    Am J Kidney Dis; 1998 Jun 10; 31(6):932-9. PubMed ID: 9631836
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
    Fujinaga S, Ohtomo Y, Hirano D, Nishizaki N, Someya T, Ohtsuka Y, Kaneko K, Shimizu T.
    Clin Nephrol; 2009 Oct 10; 72(4):268-73. PubMed ID: 19825332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.